Pharma-Compliant Testing of Elemental Impurities Testing Pharmaceuticals with ICP-MS, ICP-OES & AAS in Pharma QC

Content and goals of the Web Seminar

Duration: ~40 min
Language: English
Speakers:
Franz Lehmann, Application Specialist ICP MS
Holger Sievers, Product Manager AAS 

Regulatory requirements in pharmaceutical analytics are becoming increasingly stringent. For elemental impurities in pharmaceuticals, USP <232> and <233> chapters define limits of toxic elements and specify analytical procedures for their detection. This webinar explains how elemental analysis with ICP-MS, ICP-OES, and AAS supports compliance with USP <232> , USP <233> and other norms.  You'll gain insight into method requirements such as system suitability, accuracy, and specificity—particularly for Class 1, 2, and 3 elements. Practical examples from pharmaceutical quality control show how to apply these techniques efficiently, e.g. for trace element analysis in drug formulations.

AAS will be covered as a suitable method for specific applications, e.g. analysis of electrolyte solutions, where fewer elements need to be monitored. The session addresses common challenges in implementing compliant workflows and demonstrates how analytical systems can be integrated into routine lab operations with minimal complexity. Ideal for laboratories looking to strengthen regulatory compliance, improve data quality, and ensure consistent monitoring of raw materials and finished products.

Key Learning Objectives:

  • Overview of USP <232> and <233>
  • Practical insights into ICP-OES, ICP-MS and AAS
  • Technology comparison: strengths, limitations, and application areas
  • Live Q&A with our application experts